explore -WSS

explore

author：focus 2025-09-29 01:36:51 - browse：587

A pile of medical bills — Medicare coverage from STAT — Medicare will force hospitals to be better about publishing the prices they charge health insurers and patients. Don Petersen/AP

The federal government is moving forward with a spate of proposals that will force hospitals to be better about publishing the prices they charge health insurers and patients.

Federal law has required hospitals to post their prices since 2021. Compliance has been dismal, although it has improved since the government increased fines a few years ago. But the pricing information is still tough to find and confusing to interpret.

The latest regulations, which take effect next year, attempt to streamline reporting. Hospitals already have to publish a machine-readable file listing their prices, but next year, they will have to use a standard template, created by the government, so the information is more uniform and understandable.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Readout Newsletter: Biotech news, including Moderna's Covid vaccine

hotspot

WSS

When women are denied an abortion, their children fare worse than peers

FDA's Pazdur wants cancer trials to range beyond China alone

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Bristol 'take

Why age limits for politicians are a terrible idea

knowledge

explore

explore

Cancer drug shortages should be causing more outrage

Cord blood banking comes at a high cost to babies

Continuity nursing helped my family in our darkest PICU moments

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The future of health care in the House

Apple is now the first public company to be valued at $3 trillion

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

New air purifier tech could be key to improving indoor air quality

FDA panel signals lack of confidence in Amgen cancer drug data

entertainment

Why age limits for politicians are a terrible idea

BMI, flaws aside, is found to be useful estimate of body fat in youth

With trial win, GSK could get blood cancer drug back on market

FDA's Pazdur wants cancer trials to range beyond China alone

Shifting the focus from loneliness to social health

Phenylephrine and the overlooked value of the placebo effect

hotspot

explore

hotspot

knowledge